Document is current
Any future updates will be listed below
-
Authors
Vainio, S. K. http://orcid.org/0000-0001-5171-7480
Dickens, A. M. http://orcid.org/0000-0002-3178-8449
Matilainen, M. http://orcid.org/0000-0002-5597-2670
López-Picón, F. R. http://orcid.org/0000-0002-3871-1735
Aarnio, R. http://orcid.org/0000-0002-6420-514X
Eskola, O. http://orcid.org/0000-0002-9874-5662
Solin, O. http://orcid.org/0000-0003-1026-4029
Anthony, D. C. http://orcid.org/0000-0003-1380-6655
Rinne, J. O. http://orcid.org/0000-0001-6369-0764
Airas, L. http://orcid.org/0000-0002-9751-5881
Haaparanta-Solin, M. http://orcid.org/0000-0002-3602-4587
-
Funding
Funding for this research was provided by:
Seventh Framework Programme (HEALTH-F2-2011-278850)
Svenska Kulturfonden
Turun Yliopistosäätiö
The Finnish Concordia Fund
Sigrid Juséliuksen Säätiö
Terveyden Tutkimuksen Toimikunta
Finnish governmental research funding
Biogen
Academy of Finland
- License Information
-
More Information
Article History
Received: 25 September 2021
Accepted: 27 December 2021
First Online: 2 February 2022
Declarations
:
: Vainio S K, Matilainen M, Aarnio R, López-Picón F R, Eskola O, Solin O, Anthony D C, Airas L and Haaparanta-Solin M have no competing interests to declare. Dr. Dickens has worked part time for Orion Pharma (Finland). This study is not involved with his work at this company. Dr. Rinne reports grants from Sigrid Juselius Foundation, from the Academy of Finland and from the Finnish governmental research funding (VTR) during the conduct of the study. He also serves as a neurology consultant for CRST Oy (Clinical Research Services Turku).
